RADIKO HOLDINGS CORP. Inactive Instrument
Radiko Holdings Corp. Stock Canadian Securities Exchange
Equities
JUJU
CA75034R1029
Pharmaceuticals
| Sales 2018 | 107K 147K | Sales 2019 | 5.18M 7.13M | Capitalization | 6.17M 8.49M |
|---|---|---|---|---|---|
| Net income 2018 | -4M -5.5M | Net income 2019 | -10M -13.76M | EV / Sales 2018 | 101 x |
| Net Debt 2018 | 259K 356K | Net Debt 2019 | 1.98M 2.73M | EV / Sales 2019 | 1.57 x |
| P/E ratio 2018 |
-1.5
x | P/E ratio 2019 |
-0.53
x | Employees | - |
| Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 96.73% |
More Fundamentals
* Assessed data
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 18-04-15 |
David Rosenberg
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-09 |
Scott Reeves
BRD | Director/Board Member | 55 | 17-01-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 18-04-15 |
Scott Reeves
BRD | Director/Board Member | 55 | 17-01-31 |
Robert Yosaitis
BRD | Director/Board Member | - | 19-11-11 |
Radiko Holdings Corp., formerly International Cannabrands Inc., is a United States-based company. The Company is a pharmaceutical preparation manufacturer.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +28.51% | 676B | |
| +23.85% | 554B | |
| -8.27% | 349B | |
| +14.63% | 318B | |
| +6.45% | 291B | |
| +2.88% | 210B | |
| -0.46% | 204B | |
| -9.90% | 194B | |
| -11.83% | 144B |
